2010
DOI: 10.1016/j.jsbmb.2010.03.083
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D and prostate cancer: The role of membrane initiated signaling pathways in prostate cancer progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0
2

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 34 publications
1
14
0
2
Order By: Relevance
“…As shown in Figure 1 The data from this study supports previous observations in prostate cancer cells where 1α,25(OH) 2 D 3 decrease cell proliferation and where at least a part of the decreased proliferation has been connected an increase in the phosphorylation of JNK/SAPK and c-jun Hagberg et al, 2008;Karlsson et al, 2010). Effects on MAPK signaling pathways by 1α,25(OH) 2 D 3 is not limited to prostate cancer cells.…”
Section: Effects Of 1α25(oh) 2 D 3 On Ap1-dependent Gene Expressionsupporting
confidence: 89%
See 1 more Smart Citation
“…As shown in Figure 1 The data from this study supports previous observations in prostate cancer cells where 1α,25(OH) 2 D 3 decrease cell proliferation and where at least a part of the decreased proliferation has been connected an increase in the phosphorylation of JNK/SAPK and c-jun Hagberg et al, 2008;Karlsson et al, 2010). Effects on MAPK signaling pathways by 1α,25(OH) 2 D 3 is not limited to prostate cancer cells.…”
Section: Effects Of 1α25(oh) 2 D 3 On Ap1-dependent Gene Expressionsupporting
confidence: 89%
“…An example of a similar observation is membrane initiated signaling in skeletal muscle, where six different signaling pathways have been described for 1α,25(OH) 2 D 3 (Vasquez et al, 1996;Capiati et al, 2000;Dirks-Naylor and Lennon-Edwards, 2011). The point that there are two different vitamin D receptors (VDR, PDIA3) associated with the cell membrane (Holmen et al, 2009;Karlsson et al, 2010) and that PDIA3 has been suggested to form a trimer with at least three high affinity binding sites (Karlsson et al, 2010) make us to postulate that depending on the docking site of 1α,25(OH) 2 D 3 to the receptor, the resulting change in three dimensional structure of the hormone-receptor complex, starts a subsequent signaling cascade. The response will thus be dependent on both time and space where both short-term and long-term effect will be important in regulating prostate cell biology.…”
Section: Effects Of 1α25(oh) 2 D 3 On Tnf-α Production In Lncap Cellmentioning
confidence: 89%
“…Vitamin D promotes the differentiation of prostate cancer cells highlighting the possibility that vitamin D deficiency over time may contribute to the progression from subclinical prostate cancer to clinical disease. [13] Prior research has shown that vitamin D deficiency is an indicator of aggressive prostate cancer and spread of the disease in men who underwent their first prostate biopsy because of an abnormal PSA test. [14] Furthermore, a dose-response relationship between tumor grade and vitamin D levels was observed.…”
Section: Discussionmentioning
confidence: 99%
“…To date, a lot of studies have investigated the function of the interaction of ERp57 with calcitriol404142434445. Moreover, in a review on vitamin D analogues as potential therapeutics in melanoma, the 1,25-dihydroxy-lumisterol, locked in the 6-cis configuration, was cited as a vitamin D analogue which activates the rapid-response pathways and competes with 1α,25-dihydroxyvitamin D 3 for MARRS receptor binding, but not for VDR binding43.…”
Section: Discussionmentioning
confidence: 99%